title: Overexpression of PIP5KL1 suppresses cell proliferation and migration in human gastric cancer cells.
abstract: Phosphatidylinositol-4-phosphate 5-kinase-like 1 (PIP5KL1), the forth member of phosphatidylinositol-4-phosphate 5-kinases (PIPKs) type I, acts as a scaffold for localization and activation of PIPKs, which mediates numerous cellular processes. However, the role of PIP5KL1 in the development of human cancer is still lacking. We therefore examined the expression of PIP5KL1 in human normal and cancer tissues by tissue microarrays (TMAs). Reverse transcription-polymerase chain reaction (RT-PCR) and immunofluorescence imaging analysis were used to testify the mRNA and protein levels of PIP5KL1 in human gastric cancer cell line (BGC823). The cell proliferation was investigated with 3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-di-phenytetrazoliumromide (MTT) assay. Both wound healing and transwell migration assay were performed to study the cell migration. The phosphorylation of v-akt murine thymoma viral oncogene homolog 1 (AKT1) was determined by western immunoblot analysis. Immunostaining of gastric cancer tissue microarrays revealed a negative correlation between PIP5KL1 overexpression and gastric cancer in situ. Transient transfection PIP5KL1 induced a significant increase expression at both transcriptional and translational levels and consequent robust inhibition of proliferation (P < 0.05) and migration (P < 0.05) of BGC823 cells. Overexpression of PIP5KL1 markedly inhibited (P < 0.05) serum-induced phosphorylation of AKT1. Taken together, these studies indicate a functional negative correlation between elevated levels of PIP5KL1 and the development of human gastric cancer, suggesting that PIP5KL1 overexpression may suppress gastric cancer formation.
authors.affiliation: State Key Laboratory of Molecular Oncology, Cancer Institute and Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, People's Republic of China.
authors.forename: Lan
authors.initials: L
authors.lastname: Shi
authors.forename: Mei
authors.initials: M
authors.lastname: Zhao
authors.forename: Qing
authors.initials: Q
authors.lastname: Luo
authors.forename: Yi-Ming
authors.initials: YM
authors.lastname: Ma
authors.forename: Jia-Ling
authors.initials: JL
authors.lastname: Zhong
authors.forename: Xing-Hua
authors.initials: XH
authors.lastname: Yuan
authors.forename: Chang-Zhi
authors.initials: CZ
authors.lastname: Huang
mesh_terms: D045744:Cell Line, Tumor; D002465:Cell Movement; D049109:Cell Proliferation; D005753:Gastric Mucosa / Q000201:enzymology; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D010766:Phosphorylation; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000235:genetics / Q000378:metabolism*; D021381:Protein Transport; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D044967:Serum; D013274:Stomach Neoplasms / Q000201:enzymology* / Q000235:genetics / Q000473:pathology*; D013347:Subcellular Fractions / Q000201:enzymology; D046888:Tissue Array Analysis; D014945:Wound Healing
chemical_list: D012333:RNA, Messenger; C552353:PIP5KL1 protein, human; D017853:Phosphotransferases (Alcohol Group Acceptor); C020077:1-phosphatidylinositol-4-phosphate 5-kinase; D051057:Proto-Oncogene Proteins c-akt
references.citation: Genes Nutr. 2008 Feb;2(4):359-64
references.pmid: 18850231
references.citation: Pflugers Arch. 2007 Oct;455(1):31-44
references.pmid: 17605038
references.citation: J Biomol Screen. 2006 Jun;11(4):369-76
references.pmid: 16751333
references.citation: Adv Enzyme Regul. 1996;36:115-40
references.pmid: 8869744
references.citation: Mol Cancer Res. 2005 Apr;3(4):227-36
references.pmid: 15831676
references.citation: Cell Cycle. 2006 Mar;5(5):512-8
references.pmid: 16552185
references.citation: Crit Rev Biochem Mol Biol. 2007 Jan-Feb;42(1):15-39
references.pmid: 17364683
references.citation: Nature. 2002 Nov 7;420(6911):85-9
references.pmid: 12422219
references.citation: Cell Mol Life Sci. 2002 May;59(5):761-79
references.pmid: 12088277
references.citation: Cancer Res. 2006 Apr 15;66(8):3963-6
references.pmid: 16618711
references.citation: J Biol Chem. 2001 Jan 19;276(3):1865-72
references.pmid: 11042212
references.citation: Semin Radiat Oncol. 2008 Apr;18(2):89-97
references.pmid: 18314063
references.citation: Cell. 1999 Nov 24;99(5):521-32
references.pmid: 10589680
references.citation: Virchows Arch. 2009 Mar;454(3):353-4
references.pmid: 19190933
references.citation: J Biol Chem. 2002 Nov 15;277(46):43849-57
references.pmid: 12223494
references.citation: Nat Rev Mol Cell Biol. 2008 Feb;9(2):162-76
references.pmid: 18216772
references.citation: BMC Biotechnol. 2004 Sep 09;4:21
references.pmid: 15357872
references.citation: J Cell Sci. 2005 Apr 1;118(Pt 7):1461-72
references.pmid: 15769850
references.citation: FEBS Lett. 2003 Jul 3;546(1):25-31
references.pmid: 12829232
references.citation: J Cell Biol. 2001 Mar 5;152(5):867-76
references.pmid: 11238445
references.citation: Cell. 2007 Jun 29;129(7):1261-74
references.pmid: 17604717
references.citation: Adv Enzyme Regul. 2008;48:55-72
references.pmid: 18167315
references.citation: Mol Cell Biol. 2005 May;25(10):3956-66
references.pmid: 15870270
references.citation: Biochim Biophys Acta. 2005 Jul 15;1735(2):89-100
references.pmid: 15967713
references.citation: J Membr Biol. 2003 Jul 15;194(2):77-89
references.pmid: 14502432
references.citation: Mol Biol Cell. 1998 Dec;9(12):3547-60
references.pmid: 9843587
references.citation: J Biol Chem. 2004 Mar 19;279(12):11672-9
references.pmid: 14701839
references.citation: Oncogene. 2004 Feb 19;23(7):1354-63
references.pmid: 14691457
references.citation: Cell Biol Int. 2005 Jul;29(7):514-20
references.pmid: 15994099
references.citation: Nature. 2002 Nov 7;420(6911):89-93
references.pmid: 12422220